Nature Communications (Oct 2020)
A gene expression signature of TREM2hi macrophages and γδ T cells predicts immunotherapy response
Abstract
Most cancer patients do not respond to immune checkpoint therapies and the availability of predictive biomarkers is limited. Here the authors propose a signature enriched for genes of TREM2hi macrophages and γδ T cells to predict response to immunotherapy.